• FirefoxInstall the new Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.27%

    Arrowhead Research Corp. (ARWR)

    -NasdaqGS
    6.74 Down 0.15(2.18%) 4:00PM EDT
    Add to Portfolio
    Prev Close:6.89
    Open:6.83
    Bid:6.79 x 400
    Ask:7.13 x 800
    1y Target Est:14.50
    Beta:2.99
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:6.50 - 6.88
    52wk Range:4.95 - 18.87
    Volume:1,451,296
    Avg Vol (3m):2,193,420
    Market Cap:369.30M
    P/E (ttm):N/A
    EPS (ttm):-1.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARWRDown 2.18%369.30M
    PENCDown 9.68%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,250.06
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-15) :-1.47
    Quarterly EPS Est (Mar-15) :-0.37
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-0.72

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arrowhead Research Corporation develops novel drugs to treat intractable diseases in the United States. The company’s principal product candidates comprise ARC-520, an RNAi-based therapeutic that is in Phase IIa clinical trial to treat chroni... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback